Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
European Radiology|December 20, 2023
Quantitative metrics of the LV trabeculated layer by cardiac CT and cardiac MRI in patients with suspected noncompaction cardiomyopathyAshish Manohar, Davis M Vigneault, Deborah H Kwon, et al.
JACC. Heart Failure|January 4, 2024
Mavacamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: Interim Results From the MAVA-LTE Study, EXPLORER-LTE CohortFlorian Rader, Artur Oręziak, Lubna Choudhury, et al.
Nature Communications|July 18, 2023
Mislocalization of pathogenic RBM20 variants in dilated cardiomyopathy is caused by loss-of-interaction with Transportin-3Julia Kornienko, Marta Rodríguez-Martínez, Kai Fenzl, et al.
Journal of the American College of Cardiology|July 7, 2022
Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction TherapyMilind Y Desai, Anjali Owens, Jeffrey B Geske, et al.
Circulation|November 6, 2022
Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 WeeksMilind Y Desai, Anjali Owens, Jeffrey B Geske, et al.
Heart Rhythm|April 9, 2026
Atrial Fibrillation in Hypertrophic Cardiomyopathy: A Unique Clinical Entity Requiring Dedicated StudyEthan J Rowin, Konstantinos C Siontis, Anjali Owens, et al.
Journal of Cardiovascular Computed Tomography|August 22, 2025
Cardiac CT fractal analysis of LV noncompaction and common cardiomyopathiesAshish Manohar, Ashley Wong, Edgard Castillo, et al.
HGG Advances|August 26, 2024
Facilitating return of actionable genetic research results from a biobank repository: Participant uptake and utilization of digital interventionsLillian Phung, Elisabeth Wood, Brian Egleston, et al.
European Journal of Medical Genetics|November 15, 2025
An electronic review of clinical outcomes after return of actionable genetic research results from a health system research biobankGiorgio Cocchella, Lillian Phung, Elisabeth Wood, et al.
Circulation. Cardiovascular Imaging|November 6, 2022
Myosin Inhibition and Left Ventricular Diastolic Function in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy: Insights From the VALOR-HCM StudyPaul C Cremer, Jeffrey B Geske, Anjali Owens, et al.
Pageof 7